Earlier quoted context omitted.
the mRNA style viruses will probably decrease in cost exponentially the same way that DNA sequencing and computer technology have dropped in price.
However, mRNA vaccines require low temperature storage and are in general harder to handle. This translates to additional cost in production, throughout the logistics chain and delivery.
Oxford University breakthrough on global COVID-19 vaccine
161–170 of 569 posts
Re: Oxford University breakthrough on global COVID-19 vaccine
#162Re: Oxford University breakthrough on global COVID-19 vaccine
#163Why do they sabotaged their own messaging by using the 70% number? Reading further, it looks like the vaccine is 90% efficient. Also, "There were no hospitalised or severe cases in anyone who received the vaccine". Can we infer anything from that statement? They seem to be suggesting that the infection might be less serious in the vaccinated population...
Note that only n=2,741 people received the 90% efficient dosing. That's 10+ times less than the mRNA vaccines so the confidence intervals on that number will be a lot wider
Re: Oxford University breakthrough on global COVID-19 vaccine
#164Earlier quoted context omitted.
1. Smallpox vaccine is 100% effective 2. 90% is high. 3. Probably not. Immune systems are weird and incredibly complicated (think even more complicated than the brain).
I dont think its true that smallpox is 100% effective
Re: Oxford University breakthrough on global COVID-19 vaccine
#165Earlier quoted context omitted.
If they actually get to 90% or more, why would anyone bother with the more expensive and cumbersome vaccines? Except that the EU already signed a deal to buy the vaccines from AstraZeneca, Sanofi and Johnson & Johnson.
Because 95% efficacy is twice as good as 90%. And some people are willing to pay the $30 it costs to be 5% likelihood to have a non-functioning vaccine vs. a 10% likelihood the vaccine you just got won't work on you.
Re: Oxford University breakthrough on global COVID-19 vaccine
#166Earlier quoted context omitted.
[flagged]
Will you then also pay those who put huge effort and expense in to research that was perhaps necessary but didn't lead anywhere?
They then get to recover their R&D expenses and make a smaller but probably decent profit from its production.
Re: Oxford University breakthrough on global COVID-19 vaccine
#167Earlier quoted context omitted.
-80C for Pfizer, and below 0 for the other one (I forget exactly). -80C is really close to dry-ice temperatures. So I wonder if its actually -80C or if the researchers were just saying "Dry Ice".
-80C is just a pretty standard cold storage temperature in science. I'd imagine they tested stability at 4C, -20C and liquid nitrogen as well.
Re: Oxford University breakthrough on global COVID-19 vaccine
#168Earlier quoted context omitted.
I don't see why they shouldn't be able to make a fair profit.
When things go the other way, society doesn't let them make a fair loss.
Re: Oxford University breakthrough on global COVID-19 vaccine
#169Re: Oxford University breakthrough on global COVID-19 vaccine
#170Earlier quoted context omitted.
[flagged]
I don't see why they shouldn't be able to make a fair profit.
Practically speaking, I suppose a hypothetical scenario could be that the:
- the companies are granted patents
- the vaccine lasts for a limited amount of time
- before each patent expiry they companies make minor modifications (say, storage temperature requirement decreased by half a degree)
- the company make "unfair" profits by extending the oligopoly for a very long amount of time
I'm not stating that this will happen, but on the other hand, I find this plausible.